EUVIMEDOpdag EUVIMED
Crossref

Usability of a smartphone application for patients with interstitial lung disease: Results from the Registry for Better Understanding of ILD ( RE ‐ BUILD ) pilot study

Laura M Glenn iD, Dan Jackson, Carly Barton, Doris Lan iD, Lisa Fuhrmeister, Karen Symons, Louise Turnour, Ben Tefay, Anne E Holland iD, Nicole S L Goh iD, Lauren K Troy iD, Mark Brooke iD and 2 more

Respirology · 2025-02 · 30 (2) · 147-157

DOI: 10.1111/resp.14874 ↗

At a glance

Journal article in Respirology, published online on 2024-12-17. Written by Laura M Glenn and 13 co-authors. Institution: The University of Sydney School of Medicine (Central Clinical School), Sydney, New South Wales, Australia. Major MEDLINE topics: Lung Diseases, Interstitial, Mobile Applications, Smartphone. Cited 8 times so far (Crossref); 32 references. Funded by: NHMRC Centre of Research Excellence in Pulmonary Fibrosis, Lung Foundation Australia/Diana Cox Idiopathic PUlmonary Fibrosis PhD Scholarship 2019, University of Sydney, Lung Foundation Australia.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Objective Digital technologies offer opportunities for remote monitoring, increased patient engagement and incorporation of patient‐reported outcome measures (PROMs) into interstitial lung disease (ILD) care and research. This study evaluated the usability and patient experience of the RE‐BUILD (Registry for Better Understanding of ILD) application, an ILD‐specific smartphone app.

Methods

Patients with ILD aged ≥18 years were recruited from three tertiary ILD centres to use the RE‐BUILD app for 6 months. The mHealth App Usability Questionnaire (MAUQ) was evaluated at 1, 3 and 6 months and patients received monthly prompts to enter clinical and PROM data. Qualitative interviews regarding patient experience were performed in a subset of 10.

Results

Fifty patients, with mean age 66.9 ± 10.3 years, 25 (50%) female were included. Participants used the app for a median of 48 (IQR 21–178.3) sessions, equivalent to 8 sessions (IQR 3.5–29.71) per month. Median number of days that the app was accessed was 37 (IQR 14–96.8), with 13 (26%) patients using the app >30 times per month. The most accessed app feature was physical activity, followed by ‘air quality’. Participants agreed or strongly agreed that the app was easy to use (76.0%) easy to learn to use (79.8%) and well‐organized with accessible information (74.8%). The median overall MAUQ score for usability was 5.69 (IQR 5.03–6.19). There was also a high rate of engagement with app functionalities.

Conclusion

RE‐BUILD is a usable and intuitive platform for self‐monitoring and data collection in ILD. Patients report a high degree of satisfaction and have provided valuable feedback for its further development.

Subjects

MeSH terms (MEDLINE)

Lung Diseases, InterstitialMobile ApplicationsSmartphoneHumansFemaleMalePilot ProjectsAgedMiddle AgedRegistriesPatient Reported Outcome MeasuresTelemedicineSurveys and Questionnaires

Author keywords

IPFdigital healthidiopathic pulmonary fibrosisinterstitial lung diseaseself‐managementsmartphone application

Authors and institutions

  • The University of Sydney School of Medicine (Central Clinical School), Sydney, New South Wales, Australia.
  • Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
  • NHMRC Centre of Research Excellence in Pulmonary Fibrosis, Sydney, Australia.
  • Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia.
  • Department of Respiratory and Sleep Medicine, Alfred Health, Melbourne, Victoria, Australia.
  • Stacktrace Pty Ltd., Brisbane, Queensland, Australia.

ORCID profiles: Laura M Glenn, Doris Lan, Anne E Holland, Nicole S L Goh, Lauren K Troy, Mark Brooke, Tamera J Corte

Funding

  • NHMRC Centre of Research Excellence in Pulmonary Fibrosis
  • Lung Foundation Australia/Diana Cox Idiopathic PUlmonary Fibrosis PhD Scholarship 2019, University of Sydney
  • Lung Foundation Australia

Cite

APA

Glenn, L. M., Jackson, D., Barton, C., Lan, D., Fuhrmeister, L., Symons, K., Turnour, L., Tefay, B., Holland, A. E., Goh, N. S. L., Troy, L. K., Brooke, M., Glaspole, I. N., & Corte, T. J. (2025). Usability of a smartphone application for patients with interstitial lung disease: Results from the Registry for Better Understanding of ILD ( RE ‐ BUILD ) pilot study. Respirology, 30(2), 147-157. https://doi.org/10.1111/resp.14874

Vancouver

Glenn LM, Jackson D, Barton C, Lan D, Fuhrmeister L, Symons K, et al. Usability of a smartphone application for patients with interstitial lung disease: Results from the Registry for Better Understanding of ILD ( RE ‐ BUILD ) pilot study. Respirology. 2025;30(2):147-157. doi:10.1111/resp.14874

BibTeX
@article{Glenn2025,
  author = {Glenn, Laura M and Jackson, Dan and Barton, Carly and Lan, Doris and Fuhrmeister, Lisa and Symons, Karen and Turnour, Louise and Tefay, Ben and Holland, Anne E and Goh, Nicole S L and Troy, Lauren K and Brooke, Mark and Glaspole, Ian N and Corte, Tamera J},
  title = {Usability of a smartphone application for patients with interstitial lung disease: Results from the Registry for Better Understanding of ILD ( RE ‐ BUILD ) pilot study},
  journal = {Respirology},
  year = {2025},
  volume = {30},
  number = {2},
  pages = {147--157},
  doi = {10.1111/resp.14874}
}
Start for free →